The diagnostic implications of steroid binding in malignant tissues
- PMID: 324246
- DOI: 10.1016/s0065-2423(08)60170-5
The diagnostic implications of steroid binding in malignant tissues
Similar articles
-
An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.Cancer Res. 1984 Apr;44(4):1515-9. Cancer Res. 1984. PMID: 6704964
-
Heterogeneity of estrogen binding sites in mammary tumors.Breast Cancer Res Treat. 1983;3(1):61-5. doi: 10.1007/BF01806234. Breast Cancer Res Treat. 1983. PMID: 6871482
-
Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.Eur J Cancer (1965). 1980;Suppl 1:63-6. Eur J Cancer (1965). 1980. PMID: 7318871 No abstract available.
-
Estrogen receptors in the spectrum of breast cancer.Curr Probl Cancer. 1976 Dec;1(6):1-34. doi: 10.1016/s0147-0272(76)80011-6. Curr Probl Cancer. 1976. PMID: 798657 Review. No abstract available.
-
Competition between steroids for hormonal receptor.Natl Cancer Inst Monogr. 1971 Dec;34:77-87. Natl Cancer Inst Monogr. 1971. PMID: 4258783 Review. No abstract available.
Cited by
-
Characterisation of a messenger RNA selectively expressed in human breast cancer.Br J Cancer. 1989 Aug;60(2):168-75. doi: 10.1038/bjc.1989.245. Br J Cancer. 1989. PMID: 2765362 Free PMC article.